Trial intelligence / Profile preview

Betahistine for prevention of nausea and vomiting after laparoscopic cholecystectomy

IRCT20200902048594N1Phase 3Completed

Sponsor
Islamic Azad University
Start
Sep 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial in postoperative nausea and vomiting (PONV) comparing Betahistine with Placebo (2 arms). Primary endpoints: Severity of nausea and vomiting and Frequency of vomiting. Started Sep 2020; status: completed.

02

Drugs

betahistine
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on IRCT20200902048594N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200902048594N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call